EMILY ROHAN: Open Payments
NPI 1932811718 · WINTER HAVEN, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,134 in 59 payments from 20 companies in 2025. Trend: 2023 $787 · 2024 $975 · 2025 $1,134
Food & beverage: $1,134
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $139 |
| Novartis Pharmaceuticals Corporation | 7 | $130 |
| Dexcom, Inc. | 6 | $110 |
| Amneal Pharmaceuticals LLC | 5 | $102 |
| Ascendis Pharma Endocrinology Inc | 4 | $96 |
| Insulet Corporation | 3 | $85 |
| Lilly USA, LLC | 3 | $64 |
| Corcept Therapeutics | 3 | $64 |
| ABBVIE INC. | 3 | $54 |
| BETA BIONICS, INC. | 2 | $42 |
Products named: LEQVIO, Dexcom G6 Transmitter, UNITHROID, Yorvipath, Ozempic, Omnipod, MOUNJARO, Korlym.
Industry payments across FL — which companies pay providers there.
